Literature DB >> 20623385

Is deep vein thrombosis prophylaxis appropriate in the medical wards? A clinical pharmacists' intervention study.

Hossein Khalili1, Simin Dashti-Khavidaki, Azita Hajhossein Talasaz, Laleh Mahmoudi, Kaveh Eslami, Hamed Tabeefar.   

Abstract

OBJECTIVE: Venous thromboembolism is a major cause of mortality and morbidity in hospitalized patients. To evaluate physicians' approach to patients' thrombosis risk assessment and practice of thromboembolism prophylaxis in a teaching hospital, we designed an interventional prospective study.
SETTING: This pre and post interventional study was conducted in the infectious diseases ward of Imam Khomeini referral hospital, Tehran, Iran.
METHOD: Patients' risk factors for thromboembolism during hospitalization course and physicians' thromboembolism prophylaxis approaches were evaluated in a pre and post clinical pharmacists' interventional study. MAIN OUTCOME MEASURE: An internal guideline for prescribing anticoagulants as deep vein thrombosis (DVT) prophylaxis was prepared by clinical pharmacists and the appropriateness of anticoagulants' prescription was evaluated and compared before and after the implementation of consensual guideline.
RESULTS: In the pre-intervention phase 69.9% of patients had appropriate indication and received thromboembolism prophylaxis and in 31.1% of enrolled patients anticoagulants were prescribed inappropriately. Prescription of anticoagulants was appropriate in 88.4% of patients during the post interventional phase of the study while 11.6% of admitted patients received prophylaxis improperly. A decrease in the number of patients who had the criterion for DVT prophylaxis but anticoagulants were not administered after the implementation of internal guideline was statistically significant (P=0.001).
CONCLUSION: The implementation of clinical pharmacists' prepared protocol helped to a great extent in the improvement of administrating DVT prophylaxis appropriately in patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20623385     DOI: 10.1007/s11096-010-9412-y

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN: 0928-1231


  30 in total

Review 1.  The role of smoking in coagulation and thromboembolism in chronic obstructive pulmonary disease.

Authors:  Victor F Tapson
Journal:  Proc Am Thorac Soc       Date:  2005

2.  Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial.

Authors:  Alexander T Cohen; Bruce L Davidson; Alexander S Gallus; Michael R Lassen; Martin H Prins; Witold Tomkowski; Alexander G G Turpie; Jan F M Egberts; Anthonie W A Lensing
Journal:  BMJ       Date:  2006-01-26

Review 3.  The changing pattern of venous thromboembolic disease.

Authors:  A T Cohen; R A Edmondson; M J Phillips; V P Ward; V V Kakkar
Journal:  Haemostasis       Date:  1996 Mar-Apr

Review 4.  Prophylaxis of venous thromboembolism in medical patients.

Authors:  A T Cohen; R Alikhan
Journal:  Curr Opin Pulm Med       Date:  2001-09       Impact factor: 3.155

Review 5.  Thromboprophylaxis in medical patients: focus on France.

Authors:  Jean-François Bergmann; Stéphane Mouly
Journal:  Semin Thromb Hemost       Date:  2002-08       Impact factor: 4.180

6.  Utilization of venous thromboembolism prophylaxis in the medical intensive care unit.

Authors:  M G Keane; E P Ingenito; S Z Goldhaber
Journal:  Chest       Date:  1994-07       Impact factor: 9.410

7.  Physician practices in the prevention of venous thromboembolism.

Authors:  F A Anderson; H B Wheeler; R J Goldberg; D W Hosmer; A Forcier; N A Patwardhan
Journal:  Ann Intern Med       Date:  1991-10-15       Impact factor: 25.391

8.  A prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosis.

Authors:  Samuel Z Goldhaber; Victor F Tapson
Journal:  Am J Cardiol       Date:  2004-01-15       Impact factor: 2.778

Review 9.  The epidemiology of venous thromboembolism.

Authors:  Richard H White
Journal:  Circulation       Date:  2003-06-17       Impact factor: 29.690

10.  Improving the use of anticoagulant therapies in acutely ill medical patients.

Authors:  Paul P Dobesh; Katherine W Phillips; Stuart T Haines
Journal:  Am J Health Syst Pharm       Date:  2008-08-01       Impact factor: 2.637

View more
  11 in total

1.  Identifying, monitoring and reducing preventable major bleeds in the hospital setting.

Authors:  Deborah Caraballo; Alex C Spyropoulos; Charles E Mahan
Journal:  J Thromb Thrombolysis       Date:  2013-07       Impact factor: 2.300

2.  Improved utilisation of venous thromboembolism prophylaxis in renal-impaired patients following a clinical pharmacist intervention.

Authors:  Naemeh Nikvarz; Zahra Seyedi
Journal:  Eur J Hosp Pharm       Date:  2019-12-11

3.  Improved venous thromboembolism prophylaxis by pharmacist-driven interventions in acutely ill medical patients in Belgium.

Authors:  Audrey Vervacke; Sophie Lorent; Serge Motte
Journal:  Int J Clin Pharm       Date:  2014-08-03

4.  Assessment of adherence to cancer-associated venous thromboembolism guideline and pharmacist's impact on anticoagulant therapy.

Authors:  Esin Aysel Kandemir; Aygin Bayraktar-Ekincioglu; Saadettin Kilickap
Journal:  Support Care Cancer       Date:  2020-08-10       Impact factor: 3.603

5.  Medication error detection in two major teaching hospitals: What are the types of errors?

Authors:  Fatemeh Saghafi; Amir H Zargarzadeh
Journal:  J Res Med Sci       Date:  2014-07       Impact factor: 1.852

6.  Clinical pharmacy services in an Iranian teaching hospital: Type, severity, resolution, and accuracy.

Authors:  Zahra Allameh; Maryam Mehrpooya; Shadi Baniasadi; Fanak Fahimi
Journal:  J Res Pharm Pract       Date:  2013-01

7.  Developing an Economic Case of Clinical Pharmacists' Interventions on Venous Thromboembolism Prophylaxis Through Service Evaluation.

Authors:  Eun Hee Lee; Victoria Bray; Robert Horne
Journal:  J Res Pharm Pract       Date:  2017 Apr-Jun

8.  Evaluation of Venous Thromboembolic Event Prophylaxis in Hospitalized Cancer Patients: A Single-Centered Retrospective Study.

Authors:  Mehdi Mohammadi; Sholeh Ebrahimpour; Zahra Jahangard-Rafsanjani
Journal:  J Res Pharm Pract       Date:  2019 Jan-Mar

9.  Implementation of vertical clinical pharmacist service on venous thromboembolism prophylaxis in hospitalized medical patients.

Authors:  Celina Setsuko Haga; Cassio Massashi Mancio; Micheline da Costa Pioner; Fabricia Aparecida de Lima Alves; Andreia Ramos Lira; João Severino da Silva; Fábio Teixeira Ferracini; Wladimir Mendes Borges Filho; João Carlos de Campos Guerra; Claudia Regina Laselva
Journal:  Einstein (Sao Paulo)       Date:  2014 Jan-Mar

10.  Appropriateness of Pharmacologic Prophylaxis against Deep Vein Thrombosis in Medical Wards of an Ethiopian Referral Hospital.

Authors:  Mohammed Biset Ayalew; Boressa Adugna Horsa; Meseret Tilahun Zeleke
Journal:  Int J Vasc Med       Date:  2018-07-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.